| Dr Gardner Scott Smith, MD | |
|
408 Wendell Ave, Lewistown, MT 59457-2261 | |
| (406) 535-1502 | |
| Not Available |
| Full Name | Dr Gardner Scott Smith |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 408 Wendell Ave, Lewistown, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720182231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MED-PHYS-LIC-43906 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Montana Medical Center | Lewistown, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Montana Medical Facilities Inc | 5395639793 | 22 |
News Archive
Two Clemson University researchers seek to make diners mindful of mindless eating. Psychology professor Eric Muth and electrical and computer engineering professor Adam Hoover have created the Bite Counter, a measurement device that will make it easier for people to monitor how much they eat.
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.
Curtin University researchers have been awarded almost $500,000 in Federal Government funding to help improve care for people with traumatic brain injury (TBI), including those in rural, remote and Aboriginal communities.
Vertex Pharmaceuticals Incorporated and the Cystic Fibrosis Foundation today announced promising results from an ongoing Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis.
› Verified 7 days ago
| Entity Name | Central Montana Medical Facilities Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497868814 PECOS PAC ID: 5395639793 Enrollment ID: O20040209000295 |
News Archive
Two Clemson University researchers seek to make diners mindful of mindless eating. Psychology professor Eric Muth and electrical and computer engineering professor Adam Hoover have created the Bite Counter, a measurement device that will make it easier for people to monitor how much they eat.
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.
Curtin University researchers have been awarded almost $500,000 in Federal Government funding to help improve care for people with traumatic brain injury (TBI), including those in rural, remote and Aboriginal communities.
Vertex Pharmaceuticals Incorporated and the Cystic Fibrosis Foundation today announced promising results from an ongoing Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis.
› Verified 7 days ago
| Entity Name | Scl Health Medical Group-butte Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477869600 PECOS PAC ID: 2466633102 Enrollment ID: O20110301000023 |
News Archive
Two Clemson University researchers seek to make diners mindful of mindless eating. Psychology professor Eric Muth and electrical and computer engineering professor Adam Hoover have created the Bite Counter, a measurement device that will make it easier for people to monitor how much they eat.
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.
Curtin University researchers have been awarded almost $500,000 in Federal Government funding to help improve care for people with traumatic brain injury (TBI), including those in rural, remote and Aboriginal communities.
Vertex Pharmaceuticals Incorporated and the Cystic Fibrosis Foundation today announced promising results from an ongoing Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gardner Scott Smith, MD 408 Wendell Ave, Lewistown, MT 59457-2261 Ph: (406) 535-1502 | Dr Gardner Scott Smith, MD 408 Wendell Ave, Lewistown, MT 59457-2261 Ph: (406) 535-1502 |
News Archive
Two Clemson University researchers seek to make diners mindful of mindless eating. Psychology professor Eric Muth and electrical and computer engineering professor Adam Hoover have created the Bite Counter, a measurement device that will make it easier for people to monitor how much they eat.
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Researchers at University College London have made important discoveries about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among frontline healthcare workers that could help to inform new policies for protecting staff and patients in the future.
Curtin University researchers have been awarded almost $500,000 in Federal Government funding to help improve care for people with traumatic brain injury (TBI), including those in rural, remote and Aboriginal communities.
Vertex Pharmaceuticals Incorporated and the Cystic Fibrosis Foundation today announced promising results from an ongoing Phase 2 study evaluating combinations of VX-770 and VX-809, potential medicines designed to treat the defective protein that causes cystic fibrosis.
› Verified 7 days ago
Barbara Kim Miller, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 Wendell Ave, Lewistown, MT 59457 Phone: 406-535-6262 Fax: 406-535-6298 | |
Garrett Harlan Taylor, MD Surgery Medicare: Medicare Enrolled Practice Location: 408 Wendell Ave, Lewistown, MT 59457 Phone: 406-535-1502 | |
Ronald P Skipper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 Wendell Ave, Suite 4, Lewistown, MT 59457 Phone: 406-538-6262 Fax: 406-538-6298 |